Literature DB >> 21821124

Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.

Stephen D Ginsberg1, Melissa J Alldred, Shaoli Che.   

Abstract

To evaluate molecular signatures of an individual cell type in comparison to the associated region relevant towards understanding the pathogenesis of Alzheimer's disease (AD), CA1 pyramidal neurons and the surrounding hippocampal formation were microaspirated via laser capture microdissection (LCM) from neuropathologically confirmed AD and age-matched control (CTR) subjects as well as from wild type mouse brain using single population RNA amplification methodology coupled with custom-designed microarray analysis with real-time quantitative polymerase-chain reaction (qPCR) validation. CA1 pyramidal neurons predominantly displayed downregulation of classes of transcripts related to synaptic transmission in AD versus CTR. Regional hippocampal dissections displayed downregulation of several overlapping genes found in the CA1 neuronal population related to neuronal expression, as well as upregulation of select transcripts indicative of admixed cell types including glial-associated markers and immediate-early and cell death genes. Gene level distributions observed in CA1 neurons and regional hippocampal dissections in wild type mice paralleled expression mosaics seen in postmortem human tissue. Microarray analysis was validated in qPCR studies using human postmortem brain tissue and CA1 sector and regional hippocampal dissections obtained from a mouse model of AD/Down syndrome (Ts65Dn mice) and normal disomic (2N) littermates. Classes of transcripts that have a greater percentage of the overall hybridization signal intensity within single neurons tended to be genes related to neuronal communication. The converse was also found, as classes of transcripts such as glial-associated markers were under represented in CA1 pyramidal neuron expression profiles relative to regional hippocampal dissections. These observations highlight a dilution effect that is likely to occur in conventional regional microarray and qPCR studies. Thus, single population studies of specific neurons and intrinsic circuits will likely yield informative gene expression profile data that may be subthreshold and/or underrepresented in regional studies with an admixture of cell types.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21821124      PMCID: PMC3220746          DOI: 10.1016/j.nbd.2011.07.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  75 in total

1.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

Review 2.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

3.  Transcriptional profiling of small samples in the central nervous system.

Authors:  Stephen D Ginsberg
Journal:  Methods Mol Biol       Date:  2008

4.  Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Authors:  D P Devanand; G Pradhaban; X Liu; A Khandji; S De Santi; S Segal; H Rusinek; G H Pelton; L S Honig; R Mayeux; Y Stern; M H Tabert; M J de Leon
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

5.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease.

Authors:  D M Armstrong; M D Ikonomovic; R Sheffield; R J Wenthold
Journal:  Brain Res       Date:  1994-03-14       Impact factor: 3.252

7.  Reduced hippocampal functional connectivity in Alzheimer disease.

Authors:  Greg Allen; Holly Barnard; Roderick McColl; Andrea L Hester; Julie A Fields; Myron F Weiner; Wendy K Ringe; Anne M Lipton; Matthew Brooker; Elizabeth McDonald; Craig D Rubin; C Munro Cullum
Journal:  Arch Neurol       Date:  2007-10

8.  Gene expression profiling in Werner syndrome closely resembles that of normal aging.

Authors:  Kasper J Kyng; Alfred May; Steen Kølvraa; Vilhelm A Bohr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-03       Impact factor: 11.205

9.  Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons.

Authors:  Stephen D Ginsberg; Shaoli Che
Journal:  J Comp Neurol       Date:  2005-06-20       Impact factor: 3.215

Review 10.  Functional genomic methodologies.

Authors:  Stephen D Ginsberg; Károly Mirnics
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

View more
  50 in total

1.  Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.

Authors:  Melissa J Alldred; Karen E Duff; Stephen D Ginsberg
Journal:  Neurobiol Dis       Date:  2011-11-07       Impact factor: 5.996

2.  Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.

Authors:  Chelsea T Tiernan; Stephen D Ginsberg; Bin He; Sarah M Ward; Angela L Guillozet-Bongaarts; Nicholas M Kanaan; Elliott J Mufson; Scott E Counts
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

3.  Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Yinghua Chen; Kewei Chen; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

4.  Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease.

Authors:  Nicole C Berchtold; Paul D Coleman; David H Cribbs; Joseph Rogers; Daniel L Gillen; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2012-12-27       Impact factor: 4.673

5.  Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease.

Authors:  J Vadnal; S Houston; S Bhatta; E Freeman; J McDonough
Journal:  Exp Brain Res       Date:  2012-07-19       Impact factor: 1.972

6.  Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.

Authors:  Nicole C Berchtold; Marwan N Sabbagh; Thomas G Beach; Ronald C Kim; David H Cribbs; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

Review 7.  Consequences of brain-derived neurotrophic factor withdrawal in CNS neurons and implications in disease.

Authors:  Abigail Mariga; Mariela Mitre; Moses V Chao
Journal:  Neurobiol Dis       Date:  2016-03-22       Impact factor: 5.996

8.  Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment.

Authors:  Scott E Counts; Melissa J Alldred; Shaoli Che; Stephen D Ginsberg; Elliott J Mufson
Journal:  Neuropharmacology       Date:  2013-10-25       Impact factor: 5.250

9.  Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients.

Authors:  Leonidas Chouliaras; Diego Mastroeni; Elaine Delvaux; Andrew Grover; Gunter Kenis; Patrick R Hof; Harry W M Steinbusch; Paul D Coleman; Bart P F Rutten; Daniel L A van den Hove
Journal:  Neurobiol Aging       Date:  2013-04-09       Impact factor: 4.673

Review 10.  Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.

Authors:  Yuhai Zhao; Surjyadipta Bhattacharjee; Brandon M Jones; Jim Hill; Prerna Dua; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2013-11-29       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.